Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging

Commercial Readiness and Launch Strategy Following FDA clearance, Conavi is actively preparing for U.S. commercialization. The Company expects to initiate a limited market release in select U.S.
TCTMD

TCT 686: Cost-Effectiveness of IVUS and OCT Use for Percutaneous Coronary Intervention Procedures

TCT 690: Assessing the Learning Curve for Coronary Intravascular Ultrasound Use in the Cardiac Catheterisation Laboratory. Receive the the latest news, research, and presentations from major meetings ...
TCTMD

TCT 1243: Multimodality Imaging in Acute MI (MIAMI Study): NIRS-IVUS and OCT of Vulnerable Plaques in Non-Infarct-Related Arteries in STEMI Patients

TCT 1245: First-in-human Serial Assessment of Therapeutic Modification in Coronary Plaque using Optical Coherence Tomography-Fluorescence Lifetime Imaging Receive the the latest news, research, and ...